These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9200286

  • 21. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH.
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [Abstract] [Full Text] [Related]

  • 22. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon.
    Wen J, Phillips SF, Sarr MG, Kost LJ, Holst JJ.
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G945-52. PubMed ID: 8572226
    [Abstract] [Full Text] [Related]

  • 23. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R, Koop H, Arnold R.
    Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
    [Abstract] [Full Text] [Related]

  • 24. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M, Junien JL, Reeve JR, Rivier J, Grandt D, Taché Y.
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [Abstract] [Full Text] [Related]

  • 25. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
    MacIntosh CG, Andrews JM, Jones KL, Wishart JM, Morris HA, Jansen JB, Morley JE, Horowitz M, Chapman IM.
    Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
    Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ.
    Dig Dis Sci; 1993 Apr; 38(4):665-73. PubMed ID: 8462365
    [Abstract] [Full Text] [Related]

  • 30. Effect of peptide YY on gastric, pancreatic, and biliary function in humans.
    Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR.
    Gastroenterology; 1985 Sep; 89(3):494-9. PubMed ID: 3839479
    [Abstract] [Full Text] [Related]

  • 31. Peptide YY interacts with secretin and duodenal acidification to inhibit gastric acid secretion.
    Lluis F, Gomez G, Fujimura M, Greeley GH, Townsend CM, Thompson JC.
    Regul Pept; 1987 Aug 17; 18(3-4):155-63. PubMed ID: 3671783
    [Abstract] [Full Text] [Related]

  • 32. Effect of peptide YY on gastric motor and secretory activity in vagally innervated and denervated corpus pouch dogs.
    Zai H, Haga N, Fujino MA, Itoh Z.
    Regul Pept; 1996 Mar 22; 61(3):181-8. PubMed ID: 8701034
    [Abstract] [Full Text] [Related]

  • 33. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA.
    Diabetologia; 1999 Mar 22; 42(3):373-9. PubMed ID: 10096792
    [Abstract] [Full Text] [Related]

  • 34. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
    Chelikani PK, Haver AC, Reidelberger RD.
    Diabetes; 2006 Nov 22; 55(11):3038-46. PubMed ID: 17065340
    [Abstract] [Full Text] [Related]

  • 35. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
    Plaisancie P, Bernard C, Chayvialle JA, Cuber JC.
    Endocrinology; 1994 Dec 22; 135(6):2398-403. PubMed ID: 7988423
    [Abstract] [Full Text] [Related]

  • 36. Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation.
    Claustre J, Brechet S, Plaisancie P, Chayvialle JA, Cuber JC.
    J Endocrinol; 1999 Aug 22; 162(2):271-8. PubMed ID: 10425466
    [Abstract] [Full Text] [Related]

  • 37. Inhibitory action of peptide YY on gastric acid secretion.
    Guo YS, Fujimura M, Lluis F, Tsong Y, Greeley GH, Thompson JC.
    Am J Physiol; 1987 Sep 22; 253(3 Pt 1):G298-302. PubMed ID: 2888314
    [Abstract] [Full Text] [Related]

  • 38. Structural requirements of peptide YY for biological activity at enteric sites.
    Yoshinaga K, Mochizuki T, Yanaihara N, Oshima K, Izukura M, Kogire M, Sumi S, Gomez G, Uchida T, Thompson JC.
    Am J Physiol; 1992 Nov 22; 263(5 Pt 1):G695-701. PubMed ID: 1443144
    [Abstract] [Full Text] [Related]

  • 39. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs.
    Wøjdemann M, Wettergren A, Hartmann B, Holst JJ.
    Scand J Gastroenterol; 1998 Aug 22; 33(8):828-32. PubMed ID: 9754730
    [Abstract] [Full Text] [Related]

  • 40. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
    Wager-Pagé SA, Rosenbaum G, Veale WL, Davison JS.
    Peptides; 1993 Aug 22; 14(6):1299-308. PubMed ID: 8134313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.